Wize, J., Abgarowicz, T., Wojtecka-Lukasik, E., Ksisiny, S., and Dancewicz, A. M. (1975). Annals of the Rheumatic Diseases, 34, 520-523. Activation of human leucocyte procollagenase by rheumatoid synovial tissue culture medium. Production of a factor activating leucocyte procollagenase by tissue culture of rheumatoid synovium was shown. The activator was isolated, partly purified, and shown to be thermolabile, nondialysable, and had no activity toward casein, haemoglobin, histones, and PZ-peptide. The activity of the activator was partly decreased by trypsin.
A conspicuous migration of leucocytes to inflamed joints is observed in chronic rheumatoid arthritis. This disease is associated with progressive destruction of collagenous articular andjuxta-articular structures such as cartilage, bone, and tendon. It is likely that synovial collagenase(s) (Evanson, Jeffrey, and Krane, 1968; Harris, DiBona, and Krane, 1969, 1971 ) and collagenase originating from polymorphonuclear leucocytes (Lazarus, Daniels, Brown, Bladen, and Fullmer, 1968 ) play a key role in this process.
Furthermore, there are indications that the collagenolytic activity of rheumatoid synovial fluid may be enhanced due to the conversion of leucocyte procollagenase to the active form (Kruze and Wojtecka, 1972) . Thus it can be assumed that rheumatoid synovial fluid contains an endogenous factor able to activate leucocyte procollagenase. However, the origin of the activator present in rheumatoid synovial fluid is unknown.
Procollagenase activator has been shown in culture medium oftadpole explants (Harper and Gross, 1972) and mouse long bone (Vaes, 1972) . It is reasonable then to assume that the activator present in rheumatoid but not in osteoarthrotic synovial fluid (Oronsky, Perper, and Schroder, 1973) may originate from rheumatoid synovial tissue. The results presented in this paper show that rheumatoid synovial tissue culture produces a factor activating human leucocyte procollagenase.
Materials and methods

CULTURE TECHNIQUE
Synovial tissue from patients with rheumatoid arthritis, obtained at operation, was trimmed of fat and cut into 3 mm2 pieces. Explants were cultured up to 5 days in disposable flasks in Eagle's medium as described by Evanson and others (1968) . Culture media were harvested daily and replaced with fresh ones. Each day's medium was centrifuged and dialysed against 0-05 mol/l TRIS-HCI buffer pH 7-5, containing 0-005 mol/l CaCd2.
HUMAN LEUCOCYTE PROCOLLAGENASE
White blood cells were obtained from normal adult donors. Isolation of leucocytes and preparation of leucocyte homogenate was performed as described by Kruze and Wojtecka (1972) . Leucocyte homogenate was chromatographed on DEAE Sephadex A-50 column to separate the collagenase-procollagenase mixture from the bulk of protein. Eluting buffer was 0-02 mol/l TRIS-HCI pH 8-6, containing 0-002 mol/l CaCl2 on which a linear gradient from 0 to 0-4 mol/l NaCl was superimposed. The peak eluted between 0-06 and 0-12 mol/l NaCl was taken as a partially purified procollagenase.
ISOLATION OF ACTIVATOR FROM CULTURE MEDIUM
Pooled, dialysed culture media were freed from collagenase by its adsorption on collagen fibrils according to Harper, Bloch and Gross (1971) . The resulting medium devoid of synovial collagenase was used as crude preparation of the activator in assays of its action on leucocyte procollagenase. In order to isolate the activator to identify it, pooled dialysed culture media were concentrated using Aquacide (Calbiochem, Los Angeles, Calif.), then dialysed against 0-1 mol/l TRIS-HCl buffer pH 7 5, containing 1 mol/l NaCl and 0005 mol/l CaC12, and chromatographed on a 2*4 cm x 75 cm column of Sephadex G-150 equilibrated with the same buffer. The fractions containing the activator were pooled, dialysed against 0-01 mol/l TRIS-HCI buffer pH 7 5, containing 0-005 mol/l CaCl2 and 0-2 mol/l NaCl, and further purified by separation on Sephadex G-100 column (1-6 cm x 75 cm). The effluent fractions containing the activator were pooled and stored at -20°C.
COLLAGEN
Acid soluble calf skin collagen was isolated and purified by the method of Kang, Nagai, Piez, and Gross (1966) . For assays, approximately 0-2 % collagen solution in cold 005 % acetic acid was used. Before use, collagen solution was dialysed against 0-05 mol/l TRIS-HCl pH 7-5 containing 0-2 mol/l NaCl and 0-005 mol/l CaCl2 and centrifuged to remove small fragments and particles not dissolved. The origin of collagen was checked by its susceptibility to the action of trypsin added in a final concentration of 1 % to collagen. Only 3 % of collagen was digested in this test.
ASSAY OF THE ACTIVATOR
The presence of the activator and its relative activity was estimated from the difference in the collagenolytic activity of the systems containing procollagenase with or without the activator.
ASSAY OF COLLAGENOLYTIC ACTIVITY
Collagenolytic activity was measured by determination of hydroxyproline content in soluble peptides released from reconstituted collagen fibrils as described elsewhere (Kruze and Wojtecka, 1972) . In addition, collagenolytic activity was tested by measuring changes in viscosity of collagen solution incubated in the presence of the systems tested. Viscosity measurements were performed at 25'C using Ostwald type of viscometer.
OTHER METHODS
Proteolytic activity of the activator was assayed using casein (Kunitz, 1947) , urea denatured haemoglobin (Anson, 1939) , and histones (Davies, Rita, Krakauer, and Weissmann, 1971) as substrates. Assay for collagenpeptidase activity using 4-phenylazobenzyloxy-carbonyl-L-prolyl-L-leucyl-glycyl-L-prolyl-D-arginine as a substrate was performed as described by Wilnsch and Heidrich (1963) . Hydroxyproline was determined by the method of Stegemann and Stalder (1967) and protein by the method of Lowry, Rosebrough, Farr, and Randall (1951) . Polyacrylamide gel disc electrophoresis ofcollagen degradation products was carried out according to the procedure of Nagai, Gross, and Piez (1964) .
Results and discussion
During the first 2 days of culturing rheumatoid synovium no significant collagenase activity was detected in the medium. During the following days the collagenase was produced in the excreted medium with the yield similar to that reported by Evanson and 38 others (1968) . When leucocyte procollagenase was supplemented with crude preparation ofthe activator, the collagenolytic activity of the system was increased significantly (Table I) .
When attempting to isolate the activator, the media which were pooled from the 2nd to 5th day of culture were subjected to molecular sieve chromatography on Sephadex G-150 and then on Sephadex G-100. The elution profile obtained from the second chromatography had a single, well separated peak of the activator (Fig. 1) . The partially purified activator had very low collagenolytic activity but a pronounced ability to activate the leucocyte procollagenase (Table  H) , but this activity was destroyed by heating for 10 minutes at 100°C; heating for 10 minutes at 60°C or incubation with trypsin caused only partial decrease Control without medium 10-0 * The buffer blank of 15 pg hydroxyproline and hydroxyproline contained in culture medium were subtracted from the samples. The incubation system consisted of 0-02 ml leucocyte procollagenase (300 pg protein), culture medium harvested at a day indicated (100 pg of protein), 1-5 ml collagen gel (300 gg hydroxyproline), and 005 mol/l TRIS-HCI buffer pH 7-5, containing 0-005 mol/l CaC12 added to final volume of 3 ml. t The activator (5 pg protein) was preincubated with trypsin (10 pg/ml) at room temperature for 30 min. After preincubation, 400 pg of soyabean trypsin inhibitor was added and collagenolytic activity was assayed as described in 'Materials and methods'.
The incubation system consisted of 0-02 ml leucocyte procollagenase 300 pg protein), 0-3 ml activator (5 pig protein), 1-5 ml collagen gel 300 pg hydroxyproline), and 0-05 mol/l TRIS-HCI buffer pH 7-5, containing 0-005 mol/l CaC12 added to final volume of 3 ml. in activity. There was no activity toward casein, haemoglobin, and histones, the common substrates of proteolytic enzymes. It had also no activity toward PZ-peptide.
Viscosity measurements showed that partially purified activator had no effect on collagen solution but added together with procollagenase increased its collagenolytic activity (Fig. 2) (Fig. 3) as that described for products of collagen degradation by animal collagenases (Lazarus and others, 1968; Harris and others, 1969) . The results show that the activator of leucocyte procollagenase is produced by rheumatoid synovium in tissue culture. The activator probably belongs to the class of procollagenase activators produced in tadpole explant and bone explant tissue cultures and regarded as specific proteinase (Harper and others, 1971; Vaes, 1972) . These activators act as specific proteinase(s) converting procollagenase into collagenase through limited proteolysis. However, there is as yet no proof to confirm this mechanism of procollagenase activation by the activator from rheumatoid synovial tissue culture medium.
Production of the activator by the rheumatoid synovium in tissue culture might account for the presence of the activator in the synovial fluids of patients with rheumatoid arthritis (Kruze and Wojtecka, 1972) .
Collagen degradation process seen in rheumatoid arthritis depends on a number of factors. Production of the activator of leucocyte procollagenase in conjunction with leucocyte immigration into synovial fluid and with procollagenase and collagenase released from leucocytes seems to contribute significantly to the destructive process in rheumatoid arthritis. fiq w. 
